Diabetes Attitudes Wishes and Needs
DAWN2
2 other identifiers
observational
8,985
17 countries
17
Brief Summary
The study is conducted in Africa, Asia, Europe, Japan, North America and South America. The multinational surveys will explore the experiences and unmet needs of people with diabetes, as well as those of family members of people with diabetes, and of healthcare professionals treating people with diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2012
Shorter than P25 for all trials
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2012
CompletedFirst Posted
Study publicly available on registry
January 10, 2012
CompletedStudy Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedJanuary 19, 2017
January 1, 2017
6 months
January 4, 2012
January 18, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Self-reported health and Quality of Life (QoL) (measured by the study questionnaire)
Day 1
Secondary Outcomes (5)
Psychological well-being of people with diabetes and family members measured by the study questionnaire
Day 1
Diabetes distress of people with diabetes and family members measured by the study questionnaire
Day 1
Self-reported self-management of people with diabetes measured by the study questionnaire
Day 1
Family support behaviours reported by people with diabetes and family members measured by the study questionnaire
Day 1
Patient-centred diabetes care reported by people with diabetes and health care professionals measured by the study questionnaire
Day 1
Study Arms (3)
People with Diabetes
Family Members
Healthcare Professionals
Interventions
Three separate survey questionnaires, one for each of the three diabetes groups. Each questionnaire is composed of multiple items including pre-coded (multiple choice) questions, dichotomous (yes/no) questions and rating scales.
Eligibility Criteria
The total core study population is intended to comprise 9540 people with diabetes, 2160 family members and 5040 healthcare professionals across the 18 countries participating in DAWN 2. The study population will be invited to participate by either web based or telephone recruitment, or if absolutely needed and deemed appropriate, physician recruitment (i.e. patients recruited by physicians will telephone call centres managed by the local survey research agency and will be screened by telephone).
You may qualify if:
- Adults aged at least 18 years with diabetes (type 1 or type 2: not only during pregnancy)
- Adults aged at least 18 years involved in the daily care of an adult (18 years or older) with diabetes (type 1 or type 2)
- General practitioners who personally treat at least 5 adults (18 years or older) with diabetes per month and initiate oral medication
- Diabetes specialists (endocrinologists/diabetologists) who personally treat at least 50 adults (18 years or older) with diabetes per month and prescribe oral medication, insulin or other injectable diabetes medications
- Diabetes educators (diabetes nurses/dieticians/other non-physician healthcare professionals) providing care for at least 5 adults (18 years or older) with diabetes per month
- Participants must have access to the internet, either at home or at a location convenient to them, or be able to attend a face-to-face or telephone interview, to participate in the survey
- Provision of informed consent before the start of any study-related activities
You may not qualify if:
- Individuals aged below 18 years and/or diagnosed with diabetes less than 12 months ago
- Inability to understand and comply with written and verbal instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Novo Nordisk A/Slead
Study Sites (17)
Novo Nordisk Investigational Site
Princeton, New Jersey, 08540, United States
Novo Nordisk Investigational Site
Algiers, 16035, Algeria
Novo Nordisk Investigational Site
Mississauga, L4W 4XI, Canada
Novo Nordisk Investigational Site
Beijing, Beijing Municipality, 100004, China
Novo Nordisk Investigational Site
Copenhagen S, 2300, Denmark
Novo Nordisk Investigational Site
Paris La Défense Cedex, 92932, France
Novo Nordisk Investigational Site
Mainz, 55127, Germany
Novo Nordisk Investigational Site
Bangalore, 560001, India
Novo Nordisk Investigational Site
Rome, 00144, Italy
Novo Nordisk Investigational Site
Tokyo, 1000005, Japan
Novo Nordisk Investigational Site
Mexico City, Mexico
Novo Nordisk Investigational Site
Alphen aan den Rijn, Netherlands
Novo Nordisk Investigational Site
Warsaw, PL-02-274, Poland
Novo Nordisk Investigational Site
Moscow, 119330, Russia
Novo Nordisk Investigational Site
Madrid, 28033, Spain
Novo Nordisk Investigational Site
Istanbul, 34335, Turkey (Türkiye)
Novo Nordisk Investigational Site
Crawley, RH11 9RT, United Kingdom
Related Publications (10)
Peyrot M, Burns KK, Davies M, Forbes A, Hermanns N, Holt R, Kalra S, Nicolucci A, Pouwer F, Wens J, Willaing I, Skovlund SE. Diabetes Attitudes Wishes and Needs 2 (DAWN2): a multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care. Diabetes Res Clin Pract. 2013 Feb;99(2):174-84. doi: 10.1016/j.diabres.2012.11.016. Epub 2012 Dec 27.
PMID: 23273515RESULTNicolucci A, Kovacs Burns K, Holt RI, Comaschi M, Hermanns N, Ishii H, Kokoszka A, Pouwer F, Skovlund SE, Stuckey H, Tarkun I, Vallis M, Wens J, Peyrot M; DAWN2 Study Group. Diabetes Attitudes, Wishes and Needs second study (DAWN2): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013 Jul;30(7):767-77. doi: 10.1111/dme.12245.
PMID: 23711019RESULTKovacs Burns K, Nicolucci A, Holt RI, Willaing I, Hermanns N, Kalra S, Wens J, Pouwer F, Skovlund SE, Peyrot M; DAWN2 Study Group. Diabetes Attitudes, Wishes and Needs second study (DAWN2): cross-national benchmarking indicators for family members living with people with diabetes. Diabet Med. 2013 Jul;30(7):778-88. doi: 10.1111/dme.12239.
PMID: 23701236RESULTHolt RI, Nicolucci A, Kovacs Burns K, Escalante M, Forbes A, Hermanns N, Kalra S, Massi-Benedetti M, Mayorov A, Menendez-Torre E, Munro N, Skovlund SE, Tarkun I, Wens J, Peyrot M; DAWN2 Study Group. Diabetes Attitudes, Wishes and Needs second study (DAWN2): cross-national comparisons on barriers and resources for optimal care--healthcare professional perspective. Diabet Med. 2013 Jul;30(7):789-98. doi: 10.1111/dme.12242.
PMID: 23710839RESULTFunnell M. Beyond the data: moving towards a new DAWN in diabetes. Diabet Med. 2013 Jul;30(7):765-6. doi: 10.1111/dme.12244. No abstract available.
PMID: 23710971RESULTPeyrot M, Egede LE, Campos C, Cannon AJ, Funnell MM, Hsu WC, Ruggiero L, Siminerio LM, Stuckey HL. Ethnic differences in psychological outcomes among people with diabetes: USA results from the second Diabetes Attitudes, Wishes, and Needs (DAWN2) study. Curr Med Res Opin. 2014 Nov;30(11):2241-54. doi: 10.1185/03007995.2014.947023. Epub 2014 Aug 18.
PMID: 25079662RESULTPeyrot M, Egede LE, Funnell MM, Hsu WC, Ruggiero L, Siminerio LM, Stuckey HL. US ethnic group differences in self-management in the 2nd diabetes attitudes, wishes and needs (DAWN2) study. J Diabetes Complications. 2018 Jun;32(6):586-592. doi: 10.1016/j.jdiacomp.2018.03.002. Epub 2018 Mar 8.
PMID: 29709335DERIVEDNefs G, Pouwer F. The role of hypoglycemia in the burden of living with diabetes among adults with diabetes and family members: results from the DAWN2 study in The Netherlands. BMC Public Health. 2018 Jan 18;18(1):156. doi: 10.1186/s12889-018-5064-y.
PMID: 29347915DERIVEDBarnard KD, Holt RI, Dyson PA, Cummings MH, Kanumilli N, O'Neill S, Hall G. Could the Discrepancy in Perceived Emotional Care Received and Provided Be a Barrier to Active Diabetes Self-management? Insights From the Second Diabetes Attitudes, Wishes and Needs (DAWN2) Study. Diabetes Care. 2016 Feb;39(2):e20-1. doi: 10.2337/dc15-0674. Epub 2015 Dec 30. No abstract available.
PMID: 26721814DERIVEDPeyrot M, Egede LE, Funnell MM, Hsu WC, Ruggiero L, Siminerio LM, Stuckey HL. Ethnic differences in family member diabetes involvement and psychological outcomes: results from the second Diabetes Attitudes, Wishes and Needs (DAWN2) study in the USA. Curr Med Res Opin. 2015;31(7):1297-307. doi: 10.1185/03007995.2015.1043251. Epub 2015 May 20.
PMID: 25907127DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 4, 2012
First Posted
January 10, 2012
Study Start
March 1, 2012
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
January 19, 2017
Record last verified: 2017-01